Central Trust CO Repligen Corp Transaction History

Central Trust CO

$4.01 Billion
Q2 2024

A detailed history of Central Trust CO transactions in Repligen Corp stock. As of the latest transaction made, Central Trust CO holds 24 shares of RGEN stock, worth $3,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 24 -0.0%

Holding current value

$3,502

Previous $4,000 25.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$138.78 - $176.51 $3,330 - $4,236	24 New	24 $3,000
Q1 2022 May 03, 2022	SELL	$161.19 - $257.96 $16,280 - $26,053	-101 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$194.77 - $324.21 $16,555 - $27,557	85 Added 531.25%	101 $29,000
Q2 2021 Jul 23, 2021	SELL	$165.87 - $220.95 $225,417 - $300,271	-1,359 Reduced 98.84%	16 $3,000
Q1 2021 Apr 23, 2021	SELL	$180.37 - $226.26 $22,005 - $27,603	-122 Reduced 8.15%	1,375 $267,000
Q4 2020 Jan 29, 2021	SELL	$148.08 - $206.57 $2,221 - $3,098	-15 Reduced 0.99%	1,497 $286,000
Q3 2020 Oct 22, 2020	BUY	$122.51 - $158.27 $178,864 - $231,074	1,460 Added 2807.69%	1,512 $223,000
Q1 2020 Apr 17, 2020	SELL	$84.96 - $109.14 $849 - $1,091	-10 Reduced 16.13%	52 $5,000
Q4 2019 Jan 21, 2020	SELL	$73.84 - $93.08 $1,033 - $1,303	-14 Reduced 18.42%	62 $5,000
Q3 2019 Oct 28, 2019	SELL	$76.65 - $95.51 $4,062 - $5,062	-53 Reduced 41.09%	76 $6,000
Q2 2019 Jul 12, 2019	SELL	$54.2 - $85.95 $1,084 - $1,719	-20 Reduced 13.42%	129 $0
Q1 2019 Apr 26, 2019	BUY	$49.45 - $62.8 $7,368 - $9,357	149 New	149 $0
Q1 2018 Apr 04, 2018	SELL	$30.92 - $37.27 $3,092 - $3,727	-100 Closed	0 $0
Q4 2017 Jan 23, 2018	BUY	$32.53 - $38.92 $3,253 - $3,892	100	100 $0

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

53.9M

Call Options Held

420K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account